首页> 外国专利> 8-AZABICYCLO3,2,1OCTANE COMPOUNDS AND THEIR APPLICATION AS MU-OPIOID RECEPTOR ANTAGONISTS

8-AZABICYCLO3,2,1OCTANE COMPOUNDS AND THEIR APPLICATION AS MU-OPIOID RECEPTOR ANTAGONISTS

机译:8-AZABICYCLO [3,2,1] OCEANE化合物及其作为阿片受体拮抗剂的应用

摘要

FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to new compounds of formula (I): , where: R1 is selected from -ORa, -C(O)NRaRb, -NHS(O)2Rc, -C(O)ORa; A means C1-4alkylenyl; R2 means C3-12cycloalkyl or C6-10aryl which is optionally substituted by one -ORa, one or two halogen atoms, one or two C1-3alkyls substituted by two or three halogen atoms; or one, two, three or four C1-3alkyls; G means C1-4alkylenyl; R3 is selected from hydrogen, -C(O)R4, -C(O)NHR5, -S(O)2Rc and -S(O)2NRaRb; R4 means C3-6cycloalkyl or C1-6alkyl, C3-6cycloalkyl is optionally substituted by one -ORa, and C1-6alkyl is optionally substituted by one or two substitutes selected from -ORa, -C(O)ORa, -S(O)2R6, -C(O)NRaRb, -NRaRb, -CN, C3-6cycloalkyl and phenyl; or by one -D-(CH2)j-R7 where D means , j is equal to 1, n is equal to 1 or 2; R6 means C1-3alkyl optionally substituted by R7; R7 means -C(O)ORa; R5 means C1-6alkyl, benzo[1.3]dioxole or -(CH2)q-phenyl; where phenyl is optionally substituted by one or two substitutes selected from halogen, -ORa, C1-3alkiyl and C1-3alkoxy where C1-3alkyl and C1-3alkoxy optionally substituted by 2 or 3 halogen atoms, and q is equal to 0, 1; Ra and Rb independently mean hydrogen or C1-4alkyl; and Rc means C1-3alkyl; provided when R2 means phenyl substituted in position 4, R3 is not -C(O)R4 where R4 means C1-4alkyl substituted by C(O)ORa; to their pharmaceutically acceptable salts. Also, the invention refers to a pharmaceutical composition, to a method of preparing the compound of formula (I), to compounds of formula (II), (III), to application of the compounds on any claim 1-14, to a method of analysing a biological system or a sample containing a mu-opioid receptor, and also to a method of treating a mammal suffering a disease caused by mu-opioid receptor activity.;EFFECT: production of the new biologically active compounds exhibiting mu-opioid receptor antagonist activity.;26 cl, 204 ex
机译:领域:医药,药物。物质:发明涉及式(I)的新化合物:<图像文件=“ 00000021.GIF” he =“ 42” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 73” / >,其中:R 1 从-OR a ,-C(O)NR a R b 中选择,-NHS(O) 2 R c ,-C(O)OR a ; A是指C 1-4 亚烷基; R 2 表示C 3-12 环烷基或C 6-10 芳基,其可选地被一个-OR a ,一个或两个卤素原子,被两个或三个卤素原子取代的一个或两个C 1-3 烷基;或1、2、3或4个C 1-3 烷基; G是指C 1-4 亚烷基; R 3 选自氢,-C(O)R 4 ,-C(O)NHR 5 ,-S(O)< Sub> 2 R c 和-S(O) 2 NR a R b ; R 4 是指C 3-6 环烷基或C 1-6 烷基,C 3-6 环烷基是任选的被一个-OR a 取代,并且C 1-6 烷基被一个或两个选自-OR a ,-C的取代基取代(O)OR a ,-S(O) 2 R 6 ,-C(O)NR a R b ,-NR a R b ,-CN,C 3-6 环烷基和苯基;或一个-D-(CH 2 j -R 7 ,其中D表示,j等于1,n等于1或2; R 6 是指任选被R 7 取代的C 1-3 烷基; R 7 表示-C(O)OR a ; R 5 是指C 1-6 烷基,苯并[1.3]二恶唑或-(CH 2 q -苯基其中苯基可选地被一个或两个选自卤素,-OR a ,C 1-3 烷基和C 1-3 烷氧基的取代基取代其中C 1-3 烷基和C 1-3 烷氧基任选地被2或3个卤素原子取代,并且q等于0、1; R a 和R b 独立地表示氢或C 1-4 烷基; R c 是指C 1-3 烷基;当R 2 表示在4位被取代的苯基时,R 3 不是-C(O)R 4 其中R 4 < / Sup>表示被C(O)OR a 取代的C 1-4 烷基;为其药学上可接受的盐。此外,本发明涉及药物组合物,制备式(I)的化合物的方法,式(II),(III)的化合物,在权利要求1-14中任一项的化合物的应用,方法分析含有mu-阿片受体的生物系统或样品的方法,以及治疗患有由mu-阿片受体活性引起的疾病的哺乳动物的方法。;效果:生产具有mu-阿片受体的新型生物活性化合物拮抗剂活性。; 26 cl,204 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号